Status:
COMPLETED
Clinical Analysis of Vitamin B6 in Sepsis
Lead Sponsor:
The First People's Hospital of Huzhou
Conditions:
Sepsis
Vitamin B6
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Methodology Patients A total of 128 patients with sepsis and AKI who were admitted to several centers including Huzhou first people's Hospital combined with Wuxing People's Hospital, Linghu people's H...
Eligibility Criteria
Inclusion
- 18-65 years old;
- The hospital survival time was more than 48 hours, and the medical records were complete;
- There is no history of vitamin B6 use in the recent period of admission (within 2 weeks before admission).
Exclusion
- Patients with chronic renal insufficiency or renal failure in the past;
- Related renal injury caused by reasons other than sepsis;
- At the time of admission to ICU, there was cardiac failure or cardiogenic shock in combination with sepsis;
- Patients who use nephrotoxic drugs or contrast agents;
- Previous kidney transplantation;
- Patients with restrictive use of positive inotropic drugs (such as left ventricular outflow tract stenosis);
- Age\<18 or\>65;
- pregnant woman.
Key Trial Info
Start Date :
November 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 30 2022
Estimated Enrollment :
128 Patients enrolled
Trial Details
Trial ID
NCT06008223
Start Date
November 1 2021
End Date
November 30 2022
Last Update
August 23 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Wen-Ming Feng
Huzhou, Zhejiang, China, 313000